Selective Arylation of Dichalcogenides in Biomolecules

US2016367693A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016367693-A1
Application numberUS-201615187169-A
CountryUS
Kind codeA1
Filing dateJun 20, 2016
Priority dateJun 19, 2015
Publication dateDec 22, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are chemical transformations for the conjugation of unprotected peptide biomolecules. The processes feature several significant advantages over existing methods of peptide modification, including specificity towards selenocysteine over other nucleophiles (e.g., amines, hydroxyls), excellent functional group tolerance, and mild reaction conditions.

First claim

Opening claim text (preview).

We claim: 1 . A compound comprising (a) substructure I: wherein, independently for each occurrence, A 1 is H, an amine protecting group, a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; A 5 is OH, —O(carboxylate protecting group), a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; is a substituted or unsubstituted aryl or heteroaryl radical; x is 0, 1, 2, 3, 4, 5, or 6; and R is H or alkyl; or (b) substructure II: wherein, independently for each occurrence, A 1 is H, an amine protecting group, a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; A 5 is OH, —O(carboxylate protecting group), a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; is a substituted or unsubstituted aryl or heteroaryl radical, provided is not a perfluoroaryl radical; x is 0, 1, 2, 3, 4, 5, or 6; and R is H or alkyl. 2 . The compound of claim 1 , wherein is a substituted aryl radical. 3 . The compound of claim 1 , wherein is a substituted phenyl radical. 4 . The compound of claim 1 , wherein is an unsubstituted aryl radical. 5 . The compound of claim 1 , wherein is a substituted heteroaryl radical. 6 . The compound of claim 1 , wherein is a substituted indole, pyrazolo, thiophene, pyrimidine, benzofuran, or isoxazole radical. 7 . The compound of claim 1 , wherein is an unsubstituted heteroaryl radical. 8 . The compound of claim 1 , wherein is an unsubstituted indole, pyrazolo, thiophene, pyrimidine, benzofuran, or isoxazole radical. 9 . The compound of claim 1 , wherein or a regioisomer or stereoisomer thereof. 10 . A compound comprising (a) substructure III: wherein, independently for each occurrence, A 1 is H, an amine protecting group, a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; A 2 , A 3 , and A 4 are selected from the group consisting of a natural amino acid, an unnatural amino acid, and a plurality of natural amino acids or unnatural amino acids; A 5 is OH, —O(carboxylate protecting group), a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; x is 0, 1, 2, 3, 4, 5, or 6; is a substituted or unsubstituted aryl or heteroaryl diradical; and R is H or alkyl; (b) substructure IV: wherein, independently for each occurrence, A 1 is H, an amine protecting group, a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; A 2 , A 3 , and A 4 are selected from the group consisting of a natural amino acid, an unnatural amino acid, and a plurality of natural amino acids or unnatural amino acids; A 5 is OH, —O(carboxylate protecting group), a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; x is 0, 1, 2, 3, 4, 5, or 6; is a substituted or unsubstituted aryl or heteroaryl diradical, provided is not a perfluoroaryl diradical; and R is H or alkyl; (c) substructure V or substructure VII: wherein, independently for each occurrence, A 1 is H, an amine protecting group, a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; A 2 , A 3 , and A 4 are selected from the group consisting of a natural amino acid, an unnatural amino acid, and a plurality of natural amino acids or unnatural amino acids; A 5 is OH, —O(carboxylate protecting group), a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; x is 0, 1, 2, 3, 4, 5, or 6; is a substituted or unsubstituted aryl or heteroaryl diradical; and R is H or alkyl; or (d) substructure VI or substructure VIII: wherein, independently for each occurrence, A 1 is H, an amine protecting group, a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; A 2 , A 3 , and A 4 are selected from the group consisting of a natural amino acid, an unnatural amino acid, and a plurality of natural amino acids or unnatural amino acids; A 5 is OH, —O(carboxylate protecting group), a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; x is 0, 1, 2, 3, 4, 5, or 6; is a substituted or unsubstituted aryl or heteroaryl diradical, provided is not a perfluoroaryl diradical; and R is H or alkyl. 11 . The compound of claim 10 , wherein is a substituted aryl diradical. 12 . The compound of claim 10 , wherein

Assignees

Inventors

Classifications

  • C07K1/1077Primary

    by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids · CPC title

  • the antibody targeting a determinant of a tumour cell · CPC title

  • Labelling of peptides · CPC title

  • from mammals · CPC title

  • by covalent attachment of amino acids or peptide residues · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016367693A1 cover?
Disclosed are chemical transformations for the conjugation of unprotected peptide biomolecules. The processes feature several significant advantages over existing methods of peptide modification, including specificity towards selenocysteine over other nucleophiles (e.g., amines, hydroxyls), excellent functional group tolerance, and mild reaction conditions.
Who is the assignee on this patent?
Massachusetts Inst Technology
What technology area does this patent fall under?
Primary CPC classification C07K1/1077. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Dec 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).